Effective date: September 5, 2026
Last updated: September 5, 2026

 

1. Legal Notice

This Website is owned and operated by:

Legal entity: Genome1st Europe LLC
Operating name: Genome1st Europe
Email: drpaul@genome1st.com
Website: genome1st.com

Website hosting provider:
HOSTINGER INTERNATIONAL LIMITED
61 Lordou Vironos Street
6023 Larnaca, Cyprus
Website: www.hostinger.com

Server location:
European Union

If any professional activity described on the Website is subject to licensing, professional registration, or regulatory authorization, the relevant information will be provided here or in the applicable service documentation.

2. Acceptance of These Terms

These Terms of Use govern your access to and use of [WEBSITE URL] (the “Website”).

By accessing or using the Website, you confirm that you have read and understood these Terms and agree to comply with them.

If you do not agree with these Terms, please discontinue your use of the Website.

3. About Genome1st Europe

The Website provides general information about Genome1st Europe and its activities in areas that may include:

• Clinical genomics;

• Personalized health;

• Healthcare partnerships;

• Scientific and research collaboration;

• Genomic education;

• European healthcare and biotechnology strategy;

• Professional and institutional partnerships.

The Website may also contain information about our team, events, publications, projects, services, and collaboration opportunities.

Unless expressly stated otherwise, Website content is provided for general informational, educational, scientific, and professional purposes.

4. No Medical Advice

The Website does not provide medical advice, diagnosis, treatment, emergency assistance, or individualized healthcare recommendations.

Website content should not be used as a substitute for consultation with a qualified physician, genetic counselor, or other licensed healthcare professional.

You should not disregard, delay, or change professional medical advice because of information published on the Website.

If you believe you are experiencing a medical emergency, immediately contact the appropriate emergency service. In Greece and throughout the European Union, the emergency telephone number is 112.

5. No Clinical or Professional Relationship

Visiting the Website, submitting a contact form, sending an email, or receiving general information from Genome1st does not create:

• A physician–patient relationship;

• A healthcare provider–patient relationship;

• A genetic counselor–patient relationship;

• A researcher–participant relationship;

• A professional advisory relationship;

• A contractual relationship for testing, treatment, consulting, or other services;

• An obligation for Genome1st to accept or undertake a project.

Any clinical, scientific, consulting, research, or professional engagement must be established through a separate written agreement.

Where applicable, a separate engagement may also require informed consent, regulatory approval, professional authorization, and additional privacy documentation.

6. Genetic and Health Information

Do not submit genetic information, medical records, diagnostic results, or other sensitive health information through the general contact form or ordinary email.

Sensitive information should only be provided when Genome1st has specifically requested it and supplied an approved secure transmission method.

Submitting unsolicited medical or genetic information does not require Genome1st to:

• Review or evaluate the information;

• Provide a diagnosis or recommendation;

• Retain the information;

• Accept the sender as a patient, client, or research participant;

• Take any particular action.

The processing of personal data is governed by our Privacy & Cookie Policy and applicable data-protection law.

7. Permitted Use

You may use the Website for lawful personal, professional, scientific, educational, or informational purposes.

You may view, download, or print Website content for your own non-commercial reference, provided that you:

• Do not modify the content;

• Do not remove copyright or proprietary notices;

• Do not present the content as your own;

• Do not use it in a misleading or unlawful manner;

• Do not imply an unauthorized affiliation with or endorsement by Genome1st.

Any other reproduction, republication, commercial use, adaptation, or distribution requires prior written permission from Genome1st.

8. Prohibited Use

You must not:

• Use the Website for unlawful, fraudulent, misleading, or harmful purposes;

• Attempt to gain unauthorized access to the Website or related systems;

• Interfere with Website security, performance, or availability;

• Introduce viruses, malware, malicious code, or harmful technology;

• Conduct unauthorized vulnerability testing or security scanning;

• Use automated tools to scrape or extract Website content without permission;

• Collect personal information about other users without authorization;

• Impersonate Genome1st, its representatives, partners, or another person;

• Submit false, defamatory, discriminatory, abusive, or infringing content;

• Use Website materials to make unsupported medical, scientific, or commercial claims;

• Circumvent security, access-control, or cookie-consent mechanisms;

• Use Genome1st trademarks or branding without permission.

We may restrict or suspend access when reasonably necessary to protect the Website, Genome1st, its users, or third parties.

9. Intellectual Property

Unless otherwise stated, the Website and its content are owned by or licensed to Genome1st Europe.

Protected content may include:

• Text and publications;

• Logos, names, and trademarks;

• Website design and layout;

• Graphics and illustrations;

• Photographs and videos;

• Reports and presentations;

• Scientific and educational materials;

• Software, code, and databases.

“Genome1st,” “Genome1st Europe,” associated logos, and related branding may not be used without prior written authorization.

Nothing in these Terms transfers any intellectual-property right or grants a license except for the limited right to access and use the Website as described above.

Third-party content remains the property of its respective owner.

10. Information Submitted to Genome1st

If you submit an inquiry, proposal, application, or other communication, you confirm that:

• The information is accurate to the best of your knowledge;

• You have the right to provide it;

• It does not violate another person’s rights;

• It does not contain unlawful or malicious material;

• You are authorized to disclose any information submitted on behalf of an organization.

Unless a separate confidentiality agreement has been signed, sending information through the Website does not automatically create a confidential relationship.

Please contact us before submitting confidential research, commercial, genetic, medical, technical, or proprietary information.

11. Accuracy of Website Information

We make reasonable efforts to ensure that Website information is accurate and current.

However, scientific, medical, regulatory, technological, and commercial information may change over time. We do not guarantee that all content will always be complete, current, or free from errors.

Information about research, technologies, projects, partnerships, or potential services does not constitute a guarantee of:

• Clinical effectiveness;

• Regulatory approval;

• Commercial availability;

• Research results;

• Partnership acceptance;

• A particular professional or healthcare outcome.

We may update, correct, replace, or remove Website content when reasonably necessary.

12. Third-Party Websites

The Website may contain links to third-party websites, publications, platforms, and services.

Links are provided for convenience and informational purposes. Unless expressly stated, a link does not indicate endorsement, sponsorship, partnership, or approval.

Genome1st does not control and is not responsible for third-party content, availability, security, terms, or privacy practices.

You should review the terms and privacy policies of external websites before using them.

13. Website Availability and Security

We take reasonable measures to maintain the availability and security of the Website.

However, we do not guarantee that the Website will always be:

• Available or uninterrupted;

• Free from technical errors;

• Compatible with every device or browser;

• Free from viruses or other harmful components.

We may modify, restrict, suspend, or discontinue all or part of the Website for maintenance, security, operational, or legal reasons.

We are not responsible for interruptions caused by circumstances outside our reasonable control.

14. Disclaimer of Warranties

To the extent permitted by applicable law, the Website and its content are provided on an “as available” basis for general information.

We do not provide warranties regarding:

• Continuous Website availability;

• The completeness or accuracy of every item of content;

• Suitability for a particular medical, scientific, commercial, or professional purpose;

• Specific research, regulatory, clinical, or business outcomes;

• The absence of every technical error or security risk.

Nothing in these Terms excludes a warranty, obligation, or right that cannot lawfully be excluded.

15. Limitation of Liability

To the extent permitted by applicable law, Genome1st will not be responsible for indirect or consequential losses arising solely from:

• Reliance on general Website content;

• Temporary Website unavailability;

• Use of a third-party website;

• Unauthorized or improper use of Website materials.

Nothing in these Terms limits or excludes liability where doing so would be unlawful, including liability arising from:

• Fraud or fraudulent misrepresentation;

• Intentional misconduct or gross negligence;

• Death or personal injury where liability cannot legally be excluded;

• A breach of mandatory data-protection obligations;

• Any mandatory consumer right;

• Any other liability that cannot lawfully be limited.

Liability relating to separately contracted professional services will be governed by the applicable written agreement.

16. Privacy and Cookies

Our processing of personal data and use of cookies are described in our Privacy & Cookie Policy.

Where required, optional cookies will not be activated until you provide consent.

You may review or change your preferences by selecting Cookie Settings in the Website footer.

17. Changes to the Website

We may update or modify the Website, its structure, its content, or the activities described on it.

The publication of information about a potential service or project does not create an obligation to continue offering or developing it.

18. Changes to These Terms

We may update these Terms to reflect changes to the Website, our activities, or applicable legal requirements.

The revised version will be published on this page with an updated “Last updated” date.

Changes apply from the date of publication unless otherwise stated or required by law.

Changes to these Website Terms do not automatically replace the provisions of a separately signed agreement.

19. Governing Law and Jurisdiction

These Terms are governed by the laws of Greece and applicable European Union law.

Subject to mandatory procedural and consumer-protection rights, disputes relating to the Website will be submitted to the competent courts of Athens, Greece.

If you use the Website as a consumer, nothing in these Terms deprives you of protections or jurisdictional rights that cannot lawfully be waived.

20. Severability

If any part of these Terms is found to be unlawful, invalid, or unenforceable, that provision will be applied to the maximum extent permitted or removed where necessary.

The remaining provisions will continue in effect.

21. No Waiver

A failure or delay by Genome1st in exercising a right under these Terms does not constitute a waiver of that right.

22. Contact Information

For questions regarding these Terms of Use & Legal Notice, contact:

Legal entity: Genome1st Europe LLC
Operating name: Genome1st Europe
Email: drpaul@genome1st.com
Website: genome1st.com